Fosun Pharma China

Fosunpharma is a leading healthcare group in China. It has built a strong root domestically and developed a global operation strategy. With pharmaceutical manufacturing and R&D being core business segment, together with strong presences in medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail.
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Looking for investment opportunities
Headquartner in China
Scarlett Shen
Investment manager 
Functionality

Genetronhealth China

Genetron
Website:
www.g
Company Size (Fulltime employees)
Please specify your partnering goal
visiting
Headquartner in China
Ms. Yeqing Tan
Marketing 

Grektek United States

The everbeat platform is being offered by Grektek, whose mission is to help dramatically improve cardiac care. We created everbeat to improve our ability to take care of ourselves, especially as we get older, and with a strong focus on heart health. Most existing solutions related to cardiac care are unattractive and cumbersome, and brand the patient as weak or sickly. At Grektek, we designed everbeat to be elegant and simple, allowing patients to take better care of themselves with dignity and comfort. We also believe that patients will enjoy the everbeat solution, which means they will use it consistently for a long time – and sustained use of a cardiac monitoring platform is essential to getting healthy.

Website:
everbeat.org
Company Size (Fulltime employees)
Year of foundation
2016
Please specify your partnering goal
Medical organizations looking to deploy remote patient monitoring solutions that can be proved to help their patients.
Headquartner in China
Biotech/Pharma Category
Assets Information 1
Everbeat Watch|Watch that can take a clinical grade ECG||USA
Biotech/Pharma Asset Stage
Medtech Category
Medtech Information 1
Everbeat | wearable ECG band | USA
Medtech Development Stage
Mr. Greg Eoyang
CTO 
Functionality

Haisco Pharmaceutical group China

Haisco focus on the innovative drugs and the high-end drugs, and we seek collaborative partners for the previous drugs.
Website:
www.haisco.com
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
The partners develope the innovative and the high-end drugs.
Headquartner in China
Mrs. Echo Tang
BD manager 
Functionality

Hanhai Biolabs, Inc. United States

Cross border life science accelerator and angel investor based in San Francisco Bay Area and Wuxi, China.
Company Size (Fulltime employees)
Please specify your partnering goal
Greater China rights
Headquartner in China
Dr. Alex Zhang
CEO 
Functionality

Harbour BioMed China

Harbour BioMed is a global, clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in the areas of oncology and immunological diseases to address unmet patient’s needs.
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Licensing-out and Licensing-in of targeted therapeutic areas
Headquartner in China
Atul Deshpande
Chief Strategy Officer & Head, US Operations 
Ms. Danni Wang
Senior Director, Business Development 
Functionality

Health & Life Sciences Cluster Bulgaria Bulgaria

Health & Life Science Cluster Bulgaria (www.biocluster.bg) has been founded three years ago to unify the efforts of experts, scientists, practitioners, researchers, academic institutions, startups, globally established companies, incubators, technology transfer companies, journalists, marketing and PR experts, who work for the advancement of biotechnology and life sciences field in Bulgaria.

The cluster successfully partners with a number of institutions and organizations, including Ministry of Economic, Ministry of education, BSMEPA, Sofia Municipality, Stara Zagora Municipality, Varna local authorities, Sofia Tech Park, BCCI, BESCO, Bulgarian Investment Agency, Medical University of Plovdiv, Medical University of Varna, Trakia University in Stara Zagora, CFA Bulgaria, EEN, Premium coworking spaces, PARA, United drone society, and many others.

The cluster participates in the establishment and the Management Board of the Association Bioscientific Society Bulgaria, which aims to support the development of the biosciences in Bulgaria and consolidation of a unified society of representatives of the Bulgarian bioscience community, working and studying both within Bulgaria and abroad. The cluster is a member of the Board of BRAIT (Bulgarian Employers' Association for Innovation and Technology, which is legal successor of the Bulgarian cluster association), together with Automotive Cluster, Mechatronics Cluster, BAIT, BASCOM, ICT Cluster and others.

The founding members of the cluster are into the core of the creation of The AI Cluster Bulgaria (www.aicluster.bg) in order to stimulate and create high value cross industry projects.

One of the objectives of the cluster is to stimulate, validate and promote technological progress in the sector of health & life sciences, as well as to connect scientists with business leaders, academia and media. Therefor Club Biotechnology & Life Sciences was founded at the beginning of 2020 in a collaboration with Sofia Tech Park.

The Cluster focuses its efforts on the development of a technology program at all levels: regional, national, and international.
Company Size (Fulltime employees)
Year of foundation
2018
Partnering Objectives
Please specify your partnering goal
Looking for partners
Headquartner in China
Mrs. Eskenazi Kristina
Chairwoman 
Functionality

HEC Pharm China

HEC Pharm is the pharmaceutical subsidiaries of HEC Group. There has been a public company listed in Hong Kong in HEC Pharm, and another company will be listed in Shanghai next year.

HEC Pharm focuses on the development and commercialization of pharmaceuticals for the therapeutics of anti-infectious diseases, metabolism disorders and oncology. We are hunting for the opportunities of co-development and in-license of the candidates with the potential therapeutics in previous fields.
Website:
www.hec.cn
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
out-license, in-license and co-development opportunities hunting
Headquartner in China
Lisha Chen
Senior Business Development Manager 
Functionality

Hong Kong Biotechnology Organization China

Hong Kong Biotechnology Organization is an independent nonprofit organization with the goal to promote best practice, raise awareness across the biotechnology industry while providing added value benefits to its members, whether they are students, researchers, entrepreneurs, industry bodies, public or private sector representatives.

Founded by pioneering scientists with extensive life science backgrounds and multi-cultural experience in research and development, engineering and business. Hong Kong Biotechnology Organization aims to establish and facilitate a worldwide platform for the Hong Kong biotech industry, promote awareness, encouraging and enabling international collaboration. We also provide informed opinion and technical advice to government bodies, healthcare institutions and the general public.
Company Size (Fulltime employees)
Year of foundation
2010
Partnering Objectives
Please specify your partnering goal
International Convention in Hong Kong
Headquartner in China
Your Research Tool and Service name
BIOHK2021
Service Description
Hong Kong Biotechnology Organization is going to hold an International Biotechnology Convention in Hong Kong in 2021. BIOHK2021 guarantees the perfect opportunity to best tap into this vast market, completing our biotech ecosystem as Asia emerges as the world’s next biotech powerhouse. BIOHK2021 is fully supported by HKSAR Government, where the Innovation and Technology Commission and Commerce has provided funding for our conference and the Commerce and Economic Development Bureau has made BIOHK2021 a key project in Hong Kong’s “relaunch program”. Furthermore, the event is also supported by the Torch Project from The Ministry of Science and Technology PRC. (Quoted: President Xi Jinping said ‘the Central Government will promote collaboration between Hong Kong and the Mainland on the technology front and support Hong Kong to become an international innovation and technology hub.’). These commitments to BIOHK2021 prove how essential and important the convention will be.
Target client type
All biotech stakeholders
Mr. Chris Chow
Sales Manager 
Functionality

Hony Capital China

PE/VC firm
Company Size (Fulltime employees)
Please specify your partnering goal
NA
Headquartner in China
Ms. Xi Liu
VP 
Functionality
Lindsay Liu
VP